|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
G1 Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
G1 Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Beyond Air, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Chimerix, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
TG Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
PROCEPT BioRobotics Corporation |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Axsome Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Amicus Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
BioCardia, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Apellis Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Ocular Therapeutix, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Zevra Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Repligen Corporation |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Altimmune, Inc. |
Analytica Ltd |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Minerva Neurosciences Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Atsena Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
AEterna Zentaris Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Catalyst Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
4D Molecular Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobeNewswire - 01 May 2024
|
Related companies:
Corbus Pharmaceuticals Holdings, Inc. |
|
|
|